Showing results 137 to 156 of 181
< previous
next >
| Issue Date | Title | Author(s) |
| 2022-08 | Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer. | Gugusheff, J; White, K; Fitzadam, S; Creighton, N; Engel, A; Lee, M; Thompson, SR; Chantrill, L; Young, J; Currow, D |
| 2023 | Population-level, patient-reported outcomes: a case study regarding a public health intervention that involves patients with life-limiting illnesses. | Daveson, B; Blanchard, M; Clapham, S; Draper, K; Connolly, A; Currow, D |
| 2020-12-07 | Population-Wide Data Linkage to Reduce Premature Mortality in Women Who Use Mental Health Services In NSW | Wilson, E; Tervonen, H; Currow, D; Sara, G |
| 2021-03-10 | Potentially preventable hospitalisations for physical health conditions in community mental health service users: a population-wide linkage study. | Sara, G; Chen, W; Large, M; Ramanuj, P; Curtis, J; McMillan, F; Mulder, CL; Currow, D; Burgess, P |
| 2017-07-01 | A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol | Currow, D; Watts, GJ; Johnson, M; McDonald, CF; Miners, JO; Somogyi, AA; Denehy, L; McCaffrey, N; Eckert, DJ; McCloud, P; Louw, S; Lam, L; Greene, A; Fazekas, B; Clark, KC; Fong, K; Agar, MR; Joshi, R; Kilbreath, S; Ferreira, D; Ekström, M |
| 2023-02-09 | Pregnancy associated cancer, timing of birth and clinical decision making-a NSW data linkage study. | Safi, N; Li, Z; Anazodo, A; Remond, M; Hayen, A; Currow, D; Roder, D; Hamad, N; Nicholl, M; Gordon, A; Frawley, J; Fotheringham, P; Sullivan, E |
| 2023-03-13 | Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study. | Fotheringham, P; Safi, N; Li, Z; Anazodo, A; Remond, M; Hayen, A; Currow, D; Roder, D; Hamad, N; Nicholl, M; Gordon, A; Frawley, J; Sullivan, EA |
| 2014-04-15 | Preliminary development and validation of a new endof-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life | McCaffrey, N; Skuza, P; Breaden, K; Eckermann, S; Hardy, J; Oaten, S; Briffa, M; Currow, D |
| 2023-03 | Progressive pulmonary fibrosis: an expert group consensus statement. | Rajan, SK; Cottin, V; Dhar, R; Danoff, S; Flaherty, KR; Brown, KK; Mohan, A; Renzoni, E; Mohan, M; Udwadia, Z; Shenoy, P; Currow, D; Devraj, A; Jankharia, B; Kulshrestha, R; Jones, S; Ravaglia, C; Quadrelli, S; Iyer, R; Dhooria, S; Kolb, M; Wells, AU |
| 2016-09-12 | Protocol for a systematic review of preference-based instruments for measuring care-related outcomes and their suitability for the palliative care setting | McCaffrey, N; Al-Janabi, H; Currow, D; Hoefman, R; Ratcliffe, J |
| 2021-08-09 | Providing outpatient cancer care for CALD patients: a qualitative study | Nic Giolla Easpaig, B; Tran, Y; Winata, T; Lamprell, K; Fajardo Pulido, D; Arnolda, G; Delaney, GP; Liauw, W; Smith, K; Avery, S; Rigg, K; Westbrook, J; Olver, I; Currow, D; Girgis, A; Karnon, J; Ward, RL; Braithwaite, J |
| 2018-01-01 | Providing palliative care at the end of life: Should health professionals fear regulation? | Willmott, L; White, B; Piper, D; Yates, P; Mitchell, G; Currow, D |
| 2018-10-01 | Psychometric Properties of the Needs Assessment Tool—Progressive Disease Cancer in U.K. Primary Care | Allgar, VL; Chen, H; Richfield, E; Currow, D; Macleod, U; Johnson, MJ |
| 2020-02-01 | Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility) | Higginson, IJ; Wilcock, A; Johnson, MJ; Bajwah, S; Lovell, N; Yi, D; Hart, SP; Crosby, V; Poad, H; Currow, D; Best, E; Brown, S |
| 2018-05-02 | A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment | Hardy, J; Skerman, H; Glare, P; Philip, J; Hudson, P; Mitchell, G; Martin, P; Spruyt, O; Currow, D; Yates, P |
| 2014-01-01 | Reclaiming the midnight hours: Up-to-date evidence in just one click | Johnson, C; Rushton, S; Tieman, J; Currow, D; Aranda, S |
| 2020-07-01 | Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial (vol 75, pg 50, 2020) | Currow, D; Louw, S; McCloud, P |
| 2015-09-01 | Results From Phase III Trials of Anamorelin in Advanced Non-Small Cell Lung Cancer Patients with Cachexia: ROMANA 1 and 2 | Abernethy, A; Fearon, K; Friend, J; Yan, Y; Duus, E; Currow, D |
| 2017-08-01 | ROMANA 3: A phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia | Currow, D; Temel, JS; Abernethy, A; Milanowski, J; Friend, J; Fearon, KC |
| 2019-10-01 | Safety and outcomes of <sup>177</sup>Lu-DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia | Lin, E; Chen, T; Little, A; Holliday, L; Roach, P; Butler, P; Hosking, E; Bailey, E; Elison, B; Currow, D |
